Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study

• DOI: 10.1016/j.ijrobp.2024.12.019
• Publication Date: 2025-01-02T17:12:39Z
• Authors: Yoshiyuki Nagumo; Kyosuke Hattori; Tomokazu Kimura; Yuta Sekino; Taku Naiki; Yasuyuki Kobayashi; Takashi Matsumoto; Takahiro Osawa; Yuki Kita; Masae Takemura; Bryan J. Mathis; Susumu Suzuki; Toyonori Tsuzuki; Hitoshi Ishikawa; Hiroyuki Nishiyama
• Keywords: Atezolizumab; Subclass